Complex reactions catalyzed by cytochrome P450 enzymes

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 3, 2007, Pages 314-329

  Isin, Emre M ^a   Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioactivation; Cytochrome P450; Metabolism of drugs; Oxidation reactions; Rearrangement reactions

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; AMINOOXAZOLE; ARISTOLOCHIC ACID; AROMATIC CARBOXYLIC ACID; CHLORINE; CYTOCHROME P450; DIHYDROBENZOXATHIIN; DIINDOLE; INDIGOID; INDOLE DERIVATIVE; ORGANIC COMPOUND; OXATHIIN DERIVATIVE; OXAZOLE DERIVATIVE; PIPERIDINE NITROXIDE; RADICAL; TROGLITAZONE; UNCLASSIFIED DRUG;

DEHALOGENATION; DIELS ALDER REACTION; DIMERIZATION; DRUG ACTIVITY; DRUG OXIDATION; ENZYME MECHANISM; MIGRATION; OXYGENATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; DIMERIZATION; HUMANS; HYDROXYLATION; MIXED FUNCTION OXYGENASES; OXIDATION-REDUCTION; SUBSTRATE SPECIFICITY;

ALNUS;

EID: 33846483860     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.07.003     Document Type: Review

References (84)

1. Bradshaw W.H., Conrad H.E., Corey E.J., Gunsalus I.C., and Lednicer D. Degradation of (+)-camphor. J. Am. Chem. Soc. 81 (1959) 5007
2. Zerbe K., Pylypenko O., Vitali F., Zhang W., Rouset S., Heck M., Vrijbloed J.W., Bischoff D., Bister B., Sussmuth R.D., Pelzer S., Wohlleben W., Robinson J.A., and Schlichting I. Crystal structure of OxyB, a cytochrome P450 implicated in an oxidative phenol coupling reaction during vancomycin biosynthesis. J. Biol. Chem. 277 (2002) 47476-47485
3. Lamb D.C., Guengerich F.P., Kelly S.L., and Waterman M.R. Streptomyces P450s as a model for drug discovery. Expert Opin. Drug Metab. Toxicol. 2 (2006) 27-40
4. Guengerich F.P. Rate-limiting steps in cytochrome P450 catalysis. Biol. Chem. 383 (2002) 1553-1564
5. Guengerich F.P., Krauser J.A., and Johnson W.W. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2. Biochemistry 43 (2004) 10775-10788
6. Bell L.C., and Guengerich F.P. Oxidation kinetics of ethanol by human cytochrome P450 2E1. Rate-limiting product release accounts for effects of isotopic hydrogen substitution and cytochrome b5 on steady-state kinetics. J. Biol. Chem. 272 (1997) 29643-29651
7. Schlichting I., Berendzen J., Chu K., Stock A.M., Maves S.A., Benson D.E., Sweet B.M., Ringe D., Petsko G.A., and Sligar S.G. The catalytic pathway of cytochrome P450cam at atomic resolution. Science 287 (2000) 1615-1622
8. Poulos T.L., and Johnson E.F. Structures of cytochrome P450 enzymes. In: Ortiz De Montellano P.R. (Ed). Cytochrome P450: Structure Mechanism, and Biochemistry (2005), Kluwer Academic/Plenum Publishers, New York 87-114
9. Guengerich F.P., and Johnson W.W. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in absence of substrate and variations among cytochrome P450 systems. Biochemistry 36 (1997) 14741-14750
10. Yun C.-H., Kim K.-H., Calcutt M.W., and Guengerich F.P. Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6. J. Biol. Chem. 280 (2005) 12279-12291
11. Guengerich F.P., and Macdonald T.L. Chemical mechanisms of catalysis by cytochromes P-450: a unified view. Acct. Chem. Res. 17 (1984) 9-16
12. Guengerich F.P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14 (2001) 611-650
13. Ortiz De Montellano P.R., and De Voss J.J. Substrate oxidation by cytochrome P450 enzymes. In: Ortiz De Montellano P.R. (Ed). Cytochrome P450: Structure, Mechanism, and Biochemistry (2005), Plenum Publishers, New York 183-245
14. Harris N., Cohen S., Filatov M., Ogliaro F., and Shaik S. Two-state reactivity in the rebound step of alkane hydroxylation by cytochrome P-450: origins of free radicals with finite lifetimes. Angew. Chem., Int. Ed. Engl. 39 (2000) 2003-2007
15. Shaik S., Kumar D., de Visser S.P., Altun A., and Thiel W. Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes. Chem. Rev. 105 (2005) 2279-2328
16. Toy P.H., Newcomb M., Coon M.J., and Vaz A.D.N. Two distinct electrophilic oxidants effect hydroxylation in cytochrome P-450-catalyzed reactions. J. Am. Chem. Soc. 120 (1998) 9718-9719
17. Chandrasena R.E., Vatsis K.P., Coon M.J., Hollenberg P.F., and Newcomb M. Hydroxylation by the hydroperoxy-iron species in cytochrome P450 enzymes. J. Am. Chem. Soc. 126 (2004) 115-126
18. Ogliaro F., de Visser S.P., Cohen S., Sharma P.K., and Shaik S. Searching for the second oxidant in the catalytic cycle of cytochrome P450: a theoretical investigation of the iron(III)-hydroperoxo species and its epoxidation pathways. J. Am. Chem. Soc. 124 (2002) 2806-2817
19. Newcomb M., Hollenberg P.F., and Coon M.J. Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations. Arch. Biochem. Biophys. 409 (2003) 72-79
20. Vaz A.D.N., McGinnity D.F., and Coon M.J. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3555-3560
21. Newcomb M., Le Tadic-Biadatti M.H., Chestney D.L., Roberts E.S., and Hollenberg P.F. A nonsynchronous concerted mechanism for cytochrome P-450 catalyzed hydroxylation. J. Am. Chem. Soc. 117 (1995) 12085-12091
22. Toy P.H., Newcomb M., and Hollenberg P.F. Hypersenstive mechanistic probe studies of cytochrome P450-catalyzed hydroxylation reactions. Implications for the cationic pathway. J. Am. Chem. Soc. 120 (1998) 7719-7729
23. Akhtar M., Corina D., Miller S., Shyadehi A.Z., and Wright J.N. Mechanism of the acyl-carbon cleavage and related reactions catalyzed by multifunctional P-450s: studies on cytochrome P45017a. Biochemistry 33 (1994) 4410-4418
24. Cole P.A., and Robinson C.H. Mechanistic studies on a placental aromatase model reaction. J. Am. Chem. Soc. 113 (1991) 8130-8137
25. Hackett J.C., Brueggemeier R.W., and Hadad C.M. The final catalytic step of cytochrome P450 aromatase: a density functional theory study. J. Am. Chem. Soc. 127 (2005) 5224-5237
26. 2 biosynthesis. J. Biol. Chem. 264 (1989) 141-150
27. Chang M.S., Boeglin W.E., Guengerich F.P., and Brash A.R. P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxyalcohol products. Biochemistry 35 (1996) 464-471
28. Dalvie D.K., Kalgutkar A.S., Khojasteh-Bakht S.C., Obach R.S., and O'Donnell J.P. Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem. Res. Toxicol. 15 (2002) 269-299
29. Kalgutkar A.S., and Soglia J.R. Minimising the potential for metabolic activation in drug discovery. Expert Opin. Drug Metab. Toxicol. 1 (2005) 91-141
30. Kalgutkar A.S., Gardner I., Obach R.S., Shaffer C.L., Callegari E., Henne K.R., Mutlib A.E., Dalvie D.K., Lee J.S., Nakai Y., O'Donnell J.P., Boer J., and Harriman S.P. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 6 (2005) 161-225
31. Fukushima D., Kim Y.H., Iyanagi T., and Oae S. Enzymatic oxidation of disulfides and thiolsulfinates by both rabbit liver microsomes and a reconstituted system with purified cytochrome P-450. J. Biochem. (Tokyo) 83 (1978) 1019-1027
32. Bondon A., Macdonald T.L., Harris T.M., and Guengerich F.P. Oxidation of cycloalkylamines by cytochrome P-450. Mechanism-based inactivation, adduct formation, ring expansion, and nitrone formation. J. Biol. Chem. 264 (1989) 1988-1997
33. Guengerich F.P., Crawford Jr. W.M., Domoradzki J.Y., Macdonald T.L., and Watanabe P.G. In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes. Toxicol. Appl. Pharmacol. 55 (1980) 303-317
34. Burka L.T., Plucinski T.M., and Macdonald T.L. Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 6680-6684
35. Guengerich F.P. Oxidation of halogenated compounds by cytochrome P-450, peroxidases, and model metalloporphyrins. J. Biol. Chem. 264 (1989) 17198-17205
36. He X., Cryle M.J., De Voss J.J., and de Montellano P.R. Calibration of the channel that Determines the ω-hydroxylation regiospecificity of cytochrome P450 4A1: catalytic oxidation of 12-halododecanoic acids. J. Biol. Chem. 280 (2005) 22697-22705
37. Reich H.J., and Peake S.L. Hypervalent organoiodine chemistry. Syn elimination of alkyl iodoso compounds. J. Am. Chem. Soc. 100 (1978) 4888-4889
38. Chen X., Christopher A., Jones J.P., Bell S.G., Guo Q., Xu F., Rao Z., and Wong L.L. Crystal structure of the F87W/Y96F/V247L mutant of cytochrome P-450cam with 1,3,5-trichlorobenzene bound and further protein engineering for the oxidation of pentachlorobenzene and hexachlorobenzene. J. Biol. Chem. 277 (2002) 37519-37526
39. Hartmann S., Hultschig C., Eisenreich W., Fuchs G., Bacher A., and Ghisla S. NIH shift in flavin-dependent monooxygenation: mechanistic studies with 2-aminobenzoyl-CoA monooxygenase reductase. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7831-7836
40. Gillam E.M.J., Notley L.M., Cai H., DeVoss J.J., and Guengerich F.P. Oxidation of indole by cytochrome P450 enzymes. Biochemistry 39 (2000) 13817-13824
41. Wu Z., Podust L.M., and Guengerich F.P. Expansion of substrate specificity of cytochrome P450 2A6 by mutagenesis. J. Biol. Chem. 280 (2005) 41090-41100
42. Yano J.K., Hsu M.H., Griffin K.J., Stout C.D., and Johnson E.F. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat. Struct. Biol. 12 (2005) 822-823
43. Russell G.A., and Kaupp G. Oxidation of carbanions: IV. Oxidation of indoxyl to indigo in basic solution. J. Am. Chem. Soc. 91 (1969) 3851-3859
44. Treiber A., Dansette P.M., El Amri H., Girault J.P., Ginderow D., Mornon J.P., and Mansuy D. Chemical and biological oxidation of thiophene: preparation and complete characterization of thiophene S-oxide dimers and evidence for thiophene S-oxide as an intermediate in thiophene metabolism in vivo and in vitro. J. Am. Chem. Soc. 119 (1997) 1565-1571
45. Kam P.C.A., and Nethery C.M. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 58 (2003) 28-35
46. Dalvie D.K., and O'Connell T.N. Characterization of novel dihydrothienofigurepyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes P450, and monoamine oxidases. Drug Metab. Dispos. 32 (2004) 49-57
47. Dansette P.M., Bertho G., and Mansuy D. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives. Biochem. Biophys. Res. Commun. 338 (2005) 450-455
48. Ha-Duong N.T., Marques-Soares C., Dijols S., Sari M.A., Dansette P.M., and Mansuy D. Interaction of new sulfaphenazole derivatives with human liver cytochrome P4502Cs: Structural determinants required for selective recognition by CYP2C9 and for inhibition of human CYP2Cs. Arch. Biochem. Biophys. 394 (2001) 189-200
49. Funa N., Funabashi M., Ohnishi Y., and Horinouchi S. Biosynthesis of hexahydroxyperylenequinone melanin via oxidative aryl coupling by cytochrome P-450 in Streptomyces griseus. J. Bacteriol. 187 (2005) 8149-8155
50. Zhao B., Guengerich F.P., Bellamine A., Lamb D.C., Izumikawa M., Funa N., Lei L., Podust L.M., Sundamoorthy M., Reddy L.M., Kelly S.L., Stec D., Voehler M., Falck J.R., Moore B.S., Shimada T., and Waterman M.R. Bindings of two flaviolin substrate molecules, oxidative coupling, and crystal structure of Streptomyces coelicolor A3(2) cytochrome P450 158A2. J. Biol. Chem. 280 (2005) 11599-11607
51. Zenk M.H., Gerardy R., and Stadler R. Phenol oxidative coupling of benzylisoquinoline alkoids catalyzed by regio- and stereoselective cytochrome P-450 linked plant enzymes: salutaridine and berbamunine. J. Chem. Soc. 22 (1989) 1725-1727
52. Pylypenko O., Vitali F., Zerbe K., Robinson J.A., and Schlichting I. Crystal structure of OxyC, a cytochrome P450 implicated in an oxidative C-C coupling reaction during vancomycin biosynthesis. J. Biol. Chem. 278 (2003) 46727-46733
53. Zerbe K., Woithe K., Li D.B., Vitali F., Bigler L., and Robinson J.A. An oxidative phenol coupling reaction catalyzed by oxyB, a cytochrome P450 from the vancomycin-producing microorganism. Angew. Chem., Int. Ed. Engl. 43 (2004) 6709-6713
54. Gordon W.P., Huitric A.C., Seth C.L., McClanahan R.H., and Nelson S.D. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. Drug Metab. Dispos. 15 (1987) 589-594
55. Lee J., La S., Ahn B.R., Jeong T.C., and Kim D.H. Metabolism of 1-(3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl)-3-(6-methoxypyridin-3- yl)-1-(2-trifluoromethylbenzyl)thiourea (YH3945), a novel anti-cancer drug, in rats using the 14C-labeled compound. Rapid Commun. Mass Spectrom. 18 (2004) 1901-1910
56. Egger H., Itterly W., John V., Rodebaugh R., Shimanskas C., Stancato F., and Kapoor A. Disposition and metabolism of prinomide in laboratory animals. Drug Metab. Dispos. 16 (1988) 568-575
57. Doss G.A., Miller R.R., Zhang Z., Teffera Y., Nargund R.P., Palucki B., Park M.K., Tang Y.S., Evans D.C., Baillie T.A., and Stearns R.A. Metabolic activation of a 1,3-disubstituted piperazine derivative: evidence for a novel ring contraction to an imidazoline. Chem. Res. Toxicol. 18 (2005) 271-276
58. Tang C., Subramanian R., Kuo Y., Krymgold S., Lu P., Kuduk S.D., Ng C., Feng D.M., Elmore C., Soli E., Ho J., Bock M.G., Baillie T.A., and Prueksaritanont T. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates. Chem. Res. Toxicol. 18 (2005) 934-945
59. Reilly C.A., Ehlhardt W.J., Jackson D.A., Kulanthaivel P., Mutlib A.E., Espina R.J., Moody D.E., Crouch D.J., and Yost G.S. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem. Res. Toxicol. 16 (2003) 336-349
60. Baek M.S., Kim J.Y., Myung S.W., Yim Y.H., Jeong J.H., and Kim D.H. Metabolism of dimethyl-4,4′-dimethoxy-5,6,5′, 6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) by human liver microsomes: Characterization of metabolic pathways and of cytochrome P450 isoforms involved. Drug Metab. Dispos. 29 (2001) 381-388
61. Stiborova M., Fernando R.C., Schmeiser H.H., Frei E., Pfau W., and Wiessler M. Characterization of DNA-adducts formed by aristolochic acids in the target organ (forestomach) of rats by P-32 postlabeling analysis using different chromatographic procedures. Carcinogenesis 15 (1994) 1187-1192
62. Bieler C.A., Stiborova M., Wiessler M., Cosyns J.P., deStrihou C.V., and Schmeiser H.H. P-32-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenesis 18 (1997) 1063-1067
63. Stiborova M., Frei E., Wiessler M., and Schmeiser H.H. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem. Res. Toxicol. 14 (2001) 1128-1137
64. Chae Y.-H., Thomas T., Guengerich F.P., Fu P.P., and El-Bayoumy K. Comparative metabolism of 1-, 2-, and 4-nitropyrene by human hepatic and pulmonary microsomes. Cancer Res. 59 (1999) 1473-1480
65. Yin W., Mitra K., Stearns R.A., Baillie T.A., and Kumar S. Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: evidence for a mechanism involving nitroxide radicals and heme iron. Biochemistry 43 (2004) 5455-5466
66. Seto Y., and Guengerich F.P. Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1. J. Biol. Chem. 268 (1993) 9986-9997
67. Kassahun K., Pearson P.G., Tang W., McIntosh I., Leung K., Elmore C., Dean D., Wang R., Doss G., and Baillie T.A. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem. Res. Toxicol. 14 (2001) 62-70
68. Yamazaki H., Shibata A., Suzuki M., Nakajima M., Shimada N., Guengerich F.P., and Yokoi T. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes. Drug Metab. Dispos. 27 (1999) 1260-1266
69. Reddy V.B., Karanam B.V., Gruber W.L., Wallace M.A., Vincent S.H., Franklin R.B., and Baillie T.A. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. Chem. Res. Toxicol. 18 (2005) 880-888
70. Marchetti E., Mattalia G., and Bergesi G. Ditazol metabolism in rat, rabbit and man. Arzneim. Forsch. 23 (1973) 1291-1295
71. Maurer H., and Kleff I. On the metabolism of ditazole in man. Arzneim. Forsch. 38 (1988) 1843-1845
72. Yabuki M., Shono F., Nakatsuka I., and Yoshitake A. Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist. Drug Metab. Dispos. 21 (1993) 1167-1169
73. Zhang Z., Chen Q., Li Y., Doss G.A., Dean B.J., Ngui J.S., Silva Elipe M., Kim S., Wu J.Y., Dininno F., Hammond M.L., Stearns R.A., Evans D.C., Baillie T.A., and Tang W. In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites. Chem. Res. Toxicol. 18 (2005) 675-685
74. Udwary D.W., Casillas L.K., and Townsend C.A. Synthesis of 11-hydroxyl O-methylsterigmatocystin and the role of a cytochrome P-450 in the final step of aflatoxin biosynthesis. J. Am. Chem. Soc. 124 (2002) 5294-5303
75. Walsh C. Enzymatic Reaction Mechanisms (1979), W.H. Freeman Co., San Francisco
76. Henry K.M., and Townsend C.A. Ordering the reductive and cytochrome P450 oxidative steps in demethylsterigmatocystin formation yields general insights into the biosynthesis of aflatoxin and related fungal metabolites. J. Am. Chem. Soc. 127 (2005) 3724-3733
77. Watanabe C.M.H., and Townsend C.A. The in vitro conversion of norsolorinic acid to Aflatoxin B1. An improved method of cell-free enzyme preparation and stabilization. J. Am. Chem. Soc. 120 (1998) 6231-6239
78. Kim T.W., Hwang J.Y., Kim Y.S., Joo S.H., Chang S.C., Lee J.S., Takatsuto S., and Kim S.K. Arabidopsis CYP85A2, a cytochrome P450, mediates the Baeyer-Villiger oxidation of castasterone to brassinolide in brassinosteroid biosynthesis. Plant Cell 17 (2005) 2397-2412
79. Fujioka S., and Yokota T. Biosynthesis and metabolism of brassinosteroids. Annu. Rev. Plant Biol. 54 (2003) 137-164
80. Bishop G.J., and Yokota T. Plants steroid hormones, brassinosteroids: current highlights of molecular aspects on their synthesis/metabolism, transport, perception and response. Plant Cell Physiol. 42 (2001) 114-120
81. Hashim M.F., Hakamatsuka T., Ebizuka Y., and Sankawa U. Reaction mechanism of oxidative rearrangement of flavanone in isoflavone biosynthesis. FEBS Lett. 271 (1990) 219-222
82. Liebler D.C., and Guengerich F.P. Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene. Biochemistry 22 (1983) 5482-5489
83. Ortiz de Montellano P.R. Oxygen activation and reactivity. In: Ortiz de Montellano P.R. (Ed). Cytochrome P450: Structure, Mechanism, and Biochemistry (1995), Plenum Press, New York 245-303
84. Ortiz de Montellano P.R. Oxygen activation and transfer. In: Ortiz de Montellano P.R. (Ed). Cytochrome P-450 (1986), Plenum Press, New York 217-271